SCHEMBL4023674

SCHEMBL4023674

CC/C=C/CCNC(=O)O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.50
FAAH O00519 1/20 0.50
CYP19A1 P11511 4/20 0.47
MAPT P10636 4/20 0.47
PPARG P37231 3/20 0.47
OXER1 Q8TDS5 3/20 0.47
RXRA P19793 2/20 0.47
FFAR1 O14842 2/20 0.47
CNR1 P21554 2/20 0.46
F7 P08709 3/20 0.44
F3 P13726 3/20 0.44
PPARA Q07869 3/20 0.44
PTGS1 P23219 3/20 0.44
KMT2A Q03164 2/20 0.44
PPARD Q03181 2/20 0.44
ADORA3 P0DMS8 2/20 0.44
NR1I2 O75469 2/20 0.41
PTGS2 P35354 2/20 0.41
KDM4E B2RXH2 1/20 0.41
MEN1 O00255 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4018553 1.00 ALDH1A1 (0.50) ALDH1A1FAAHCYP19A1MAPTPPARG
SCHEMBL4018545 1.00 ALDH1A1 (0.50) ALDH1A1FAAHCYP19A1MAPTPPARG
SCHEMBL4021960 0.85 EPHX2 (0.53) ALDH1A1CYP19A1MAPTPPARGOXER1
SCHEMBL4021951 0.85 EPHX2 (0.53) ALDH1A1CYP19A1MAPTPPARGOXER1
SCHEMBL1416855 0.84 EPHX2 (0.54) ALDH1A1CYP19A1MAPTPPARGOXER1
SCHEMBL4021981 0.84 EPHX2 (0.54) ALDH1A1CYP19A1MAPTPPARGOXER1
SCHEMBL4025106 0.83 F7 (0.52) ALDH1A1FAAHMAPTF7F3
SCHEMBL4025108 0.83 F7 (0.52) ALDH1A1FAAHMAPTF7F3
SCHEMBL2349805 0.80 ALDH1A1 (0.45) ALDH1A1FAAHCYP19A1MAPTPPARG
SCHEMBL2349808 0.80 ALDH1A1 (0.45) ALDH1A1FAAHCYP19A1MAPTPPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7476756-B2 Alkyl-, alkenyl- and alkynylcarbamate derivatives, their preparation and their application in therapeutics SANOFI-AVENTIS (FR) 2009-01-13 US disclosed
US-20080103197-A1 ALKYL-, ALKENYL- AND ALKYNYLCARBAMATE DERIVATIVES, THEIR PREPARATION AND THEIR APPLICATION IN THERAPEUTICS SANOFI-AVENTIS (FR) 2008-05-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080103197-A1 ALKYL-, ALKENYL- AND ALKYNYLCARBAMATE DERIVATIVES, THEIR PREPARATION AND THEIR APPLICATION IN THERAPEUTICS ALK, ALKBH3, IDH1 ALDH1A1 17/4885FAAH 258/4885CYP19A1 376/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.